Chartered Capital & Inv Intrinsic Value
Chartered Capital & Inv (CHRTEDCA) median intrinsic value is ₹144.00 from 5 valuation models (range ₹82–₹456), vs current price ₹273.95 — -47.4% downside (Trading Above Calculated Value), margin of safety -90.2%. For current market price and key ratios, visit CHRTEDCA share price screener.
CHRTEDCA Valuation Methods Summary — DCF, Graham Number & P/E
Chartered Capital & Inv intrinsic value across 5 models vs current price ₹273.95 — upside/downside and value range per method. Analyse CHRTEDCA institutional holdings to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹108.00 | ₹86.40 - ₹129.60 | -60.6% | EPS: ₹9.00, Sector P/E: 12x |
| Book Value Method | asset | ₹456.00 | ₹410.40 - ₹501.60 | +66.5% | Book Value/Share: ₹570.00, P/B: 0.8x |
| PEG Ratio Method | growth | ₹144.00 | ₹129.60 - ₹158.40 | -47.4% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹82.18 | ₹73.96 - ₹90.40 | -70.0% | Revenue Growth: 15.0%, Adj P/E: 8.6x |
| Graham Defensive Method | conservative | ₹339.74 | ₹305.77 - ₹373.71 | +24.0% | EPS: ₹9.00, BVPS: ₹570.00 |
CHRTEDCA Intrinsic Value vs Market Price — All Valuation Models
Chartered Capital & Inv fair value range ₹82–₹456 vs current market price ₹273.95 across 5 valuation models. Read Chartered Capital & Inv dividend payments for the complete payout history and dividend yield track record.
CHRTEDCA Intrinsic Value Analysis — Undervalued or Overvalued?
Chartered Capital & Inv median intrinsic value ₹144.00, current price ₹273.95 — Trading Above Calculated Value by 47.4%, margin of safety -90.2%.
What is the intrinsic value of CHRTEDCA?
Based on our comprehensive analysis using 5 different valuation methods, the estimated intrinsic value of Chartered Capital & Inv (CHRTEDCA) is ₹144.00 (median value). With the current market price of ₹273.95, this represents a -47.4% variance from our estimated fair value.
The valuation range spans from ₹82.18 to ₹456.00, indicating ₹82.18 - ₹456.00.
Is CHRTEDCA undervalued or overvalued?
Based on our multi-method analysis, Chartered Capital & Inv (CHRTEDCA) appears to be trading above calculated value by approximately 47.4%.
CHRTEDCA Financial Health — Key Ratios vs Industry Benchmarks
Chartered Capital & Inv financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.00 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 0.6% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 30.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
CHRTEDCA Cash Flow Quality — Operating & Free Cash Flow
Chartered Capital & Inv operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-14 Cr | ₹-14 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-8 Cr | ₹-8 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-4 Cr | ₹-4 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹-5 Cr | ₹-5 Cr | Negative Cash Flow | 3/10 |